The freight market commentary provider has increased its overall funding to approximately $40m following a series B round that included corporate venturing units of Hearst and Prologis.

The MIT-founded manufacturing app development spinout has now received more than $31m from investors including Vertex Ventures US, Pitango, NEA and C4 Ventures.

NIH will provide $3.5m to establish a human health-focused accelerator in five US states, with space for five biotech projects in its initial cohort.

Novel Group-backed lingerie manufacturer ThirdLove has closed a $55m funding round after investors including L Catterton pre-emptively approached the company about investing.

Vast Data has emerged from stealth with a total of $80m in funding raised over two rounds from investors such as Dell Technologies Capital.

MIT spinout Ginkgo Bioworks has set up Motif Ingredients with $90m in series A funding provided by investors including Louis Dreyfus Company and Fonterra.

Ginkgo Bioworks has spun out Motif Ingredients with $90m in series A funding provided by investors including Louis Dreyfus Company and Fonterra.

Geneos Therapeutics has received $10.5m in series A funding from investors including its parent company Inovio Pharmaceuticals.

The rental guarantee provider has collected $15m in a Silverstein Properties-backed series B round, which increased the company's overall funding to $27m.

The private equity firm’s latest fund has closed with $2.1bn from backers including endowments for specialty materials, chemicals and pharmaceuticals investments.